Literature DB >> 32330604

Animal models for liver disease - A practical approach for translational research.

Yulia A Nevzorova1, Zoe Boyer-Diaz2, Francisco Javier Cubero3, Jordi Gracia-Sancho4.   

Abstract

Animal models are crucial for improving our understanding of human pathogenesis, enabling researchers to identify therapeutic targets and test novel drugs. In the current review, we provide a comprehensive summary of the most widely used experimental models of chronic liver disease, starting from early stages of fatty liver disease (non-alcoholic and alcoholic) to steatohepatitis, advanced cirrhosis and end-stage primary liver cancer. We focus on aspects such as reproducibility and practicality, discussing the advantages and weaknesses of available models for researchers who are planning to perform animal studies in the near future. Additionally, we summarise current and prospective models based on human tissue bioengineering.
Copyright © 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ALD; Cirrhosis; Fibrosis; NAFLD; NASH; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Primary liver cancer

Year:  2020        PMID: 32330604     DOI: 10.1016/j.jhep.2020.04.011

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  38 in total

Review 1.  Role of liver sinusoidal endothelial cells in liver diseases.

Authors:  Jordi Gracia-Sancho; Esther Caparrós; Anabel Fernández-Iglesias; Rubén Francés
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-02-15       Impact factor: 46.802

Review 2.  Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction.

Authors:  Antonio Segovia-Zafra; Daniel E Di Zeo-Sánchez; Carlos López-Gómez; Zeus Pérez-Valdés; Eduardo García-Fuentes; Raúl J Andrade; M Isabel Lucena; Marina Villanueva-Paz
Journal:  Acta Pharm Sin B       Date:  2021-11-18       Impact factor: 11.413

3.  Sesamol protects against liver fibrosis induced in rats by modulating lysophosphatidic acid receptor expression and TGF-β/Smad3 signaling pathway.

Authors:  Nesma A Abd Elrazik; Mohamed El-Mesery; Mamdouh M El-Shishtawy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-06-01       Impact factor: 3.195

4.  Liver Protein Expression in NASH Mice on a High-Fat Diet: Response to Multi-Mineral Intervention.

Authors:  James Varani; Shannon D McClintock; Randall N Knibbs; Isabelle Harber; Dania Zeidan; Mohamed Ali H Jawad-Makki; Muhammad N Aslam
Journal:  Front Nutr       Date:  2022-05-11

5.  Characterizing Fibrosis and Inflammation in a Partial Bile Duct Ligation Mouse Model by Multiparametric Magnetic Resonance Imaging.

Authors:  Jia-Yi Liu; Ye-Yu Cai; Zhu-Yuan Ding; Zi-Yi Zhou; Min Lv; Huan Liu; Li-Yun Zheng; Lan Li; Yong-Heng Luo; En-Hua Xiao
Journal:  J Magn Reson Imaging       Date:  2021-09-21       Impact factor: 5.119

6.  Role of ductular reaction and ductular-canalicular junctions in identifying severe primary biliary cholangitis.

Authors:  Diletta Overi; Guido Carpino; Laura Cristoferi; Paolo Onori; Lindsey Kennedy; Heather Francis; Nicola Zucchini; Cristina Rigamonti; Mauro Viganò; Annarosa Floreani; Daphne D'Amato; Alessio Gerussi; Rosanna Venere; Gianfranco Alpini; Shannon Glaser; Domenico Alvaro; Pietro Invernizzi; Eugenio Gaudio; Vincenzo Cardinale; Marco Carbone
Journal:  JHEP Rep       Date:  2022-08-19

7.  Postprandial Glycogen Content Is Increased in the Hepatocytes of Human and Rat Cirrhotic Liver.

Authors:  Natalia N Bezborodkina; Sergey V Okovityi; Boris N Kudryavtsev
Journal:  Cells       Date:  2021-04-21       Impact factor: 6.600

Review 8.  Targeting von Willebrand factor in liver diseases: A novel therapeutic strategy?

Authors:  Dafna J Groeneveld; Lauren G Poole; James P Luyendyk
Journal:  J Thromb Haemost       Date:  2021-05-03       Impact factor: 16.036

9.  Sex specific effect of alcohol on hepatic plasmacytoid dendritic cells.

Authors:  Khaled Alharshawi; Holger Fey; Alyx Vogle; Tori Klenk; Miran Kim; Costica Aloman
Journal:  Int Immunopharmacol       Date:  2020-11-14       Impact factor: 4.932

10.  Transcriptomic Profiling of the Liver Sinusoidal Endothelium during Cirrhosis Reveals Stage-Specific Secretory Signature.

Authors:  Nicolò Manicardi; Anabel Fernández-Iglesias; Laia Abad-Jordà; Felix Royo; Mikel Azkargorta; Martí Ortega-Ribera; David Sanfeliu-Redondo; Ana Martínez-Alcocer; Felix Elortza; Amelia J Hessheimer; Constantino Fondevila; Juan José Lozano; Juan Carlos García-Pagán; Jaime Bosch; Francisco Javier Cubero; Agustín Albillos; Javier Vaquero; Juan M Falcón-Pérez; Jordi Gracia-Sancho
Journal:  Cancers (Basel)       Date:  2021-05-29       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.